Veeraraghavan J, Gutierrez C, De Angelis C, Davis R, et al. A multiparameter molecular classifier to predict response to neoadjuvant lapatinib plus trastuzumab without chemotherapy in HER2+ breast cancer. Clin Cancer Res 2023 May 17:CCR-22-3753. doi: 10.1158/1078-0432.CCR-22-3753.
PMID: 37195235